Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GPSM1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | PIK3R1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TMEM189-UBE2V1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CDCP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | BCL7A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | FAM129C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TRIM74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TUSC5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HARS | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |